|
1
|
Li B, Chen H, Xiang J, Zhang Y, Kong Y,
Garfield DH and Li H: Prevalence of lymph node metastases in
superficial esophageal squamous cell carcinoma. J Thorac Cardiovasc
Surg. 146:1198–1203. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Merkow RP, Bilimoria KY, Keswani RN, Chung
J, Sherman KL, Knab LM, Posner MC and Bentrem DJ: Treatment trends,
risk of lymph node metastasis, and outcomes for localized
esophageal cancer. J Natl Cancer Inst. 106:pii: dju1332014.
View Article : Google Scholar
|
|
3
|
McCormack VA, Menya D, Munishi MO,
Dzamalala C, Gasmelseed N, Roux Leon M, Assefa M, Osano O, Watts M,
Mwasamwaja AO, et al: Informing etiologic research priorities for
squamous cell esophageal cancer in Africa: A review of
setting-specific exposures to known and putative risk factors. Int
J Cancer. 140:259–271. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Du D, Song T, Liang X, Fang M and Wu S:
Concurrent chemoradiotherapy with elective lymph node irradiation
for esophageal cancer: A systemic review and pooled analysis of the
literature. Dis Esophagus. 30:1–9. 2017.
|
|
5
|
Liu J, Liu Q, Wang Y, Xia Z and Zhao G:
Nodal skip metastasis is associated with a relatively poor
prognosis in thoracic esophageal squamous cell carcinoma. Eur J
Surg Oncol. 42:1202–1205. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dubecz A, Kern M, Solymosi N, Schweigert M
and Stein HJ: Predictors of lymph node metastasis in surgically
resected T1 esophageal cancer. Ann Thorac Surg. 99:1879–1886. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ren X, Zhao Z, Huang W, Liu H, Dong C and
Li Y: Analysis of the characteristics and factors influencing lymph
node metastasis in thoracic esophageal carcinoma and cancer of the
gastric cardia. Hepatogastroenterology. 62:73–76. 2015.PubMed/NCBI
|
|
8
|
Zhang D, Zheng Y, Wang Z, Huang Q, Cao X,
Wang F and Liu S: Comparison of the 7th and proposed 8th editions
of the AJCC/UICC TNM staging system for esophageal squamous cell
carcinoma underwent radical surgery. Eur J Surg Oncol.
43:1949–1955. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Baba Y, Watanabe M, Shigaki H, Iwagami S,
Ishimoto T, Iwatsuki M and Baba H: Negative lymph-node count is
associated with survival in patients with resected esophageal
squamous cell carcinoma. Surgery. 153:234–241. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim KH, Chang JS, Cha JH, Lee IJ, Kim DJ,
Cho BC, Park KR and Lee CG: Optimal adjuvant treatment for
curatively resected thoracic esophageal squamous cell carcinoma: A
radiotherapy perspective. Cancer Res Treat. 49:168–177. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang S, Wang Z, Yang Z, Liu Y, Liu X,
Shang B and Jiang WP: Postoperative radiotherapy improves survival
in stage pT2N0M0 esophageal squamous cell carcinoma with high risk
of poor prognosis. Ann Surg Oncol. 23:265–272. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kajiyama Y: New Japanese classification of
esophageal cancer (11th Edition). Gan To Kagaku Ryoho.
43:1049–1052. 2016.(In Japanese). PubMed/NCBI
|
|
13
|
Cheng J, Kong L, Huang W, Li B, Li H, Wang
Z, Zhang J, Zhou T and Sun H: Explore the radiotherapeutic clinical
target volume delineation for thoracic esophageal squamous cell
carcinoma from the pattern of lymphatic metastases. J Thorac Oncol.
8:359–365. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Greenstein AJ, Litle VR, Swanson SJ,
Divino CM, Packer S and Wisnivesky JP: Effect of the number of
lymph nodes sampled on postoperative survival of lymph
node-negative esophageal cancer. Cancer. 112:1239–1246. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu Z, Chen H, Yu W, Fu X, Xiang J, Li H,
Zhang Y, Sun M, Wei Q, Zhao W and Zhao K: Number of negative lymph
nodes is associated with survival in thoracic esophageal squamous
cell carcinoma patients undergoing three-field lymphadenectomy. Ann
Surg Oncol. 21:2857–2863. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hsu PK, Huang CS, Wang BY, Wu YC, Chou TY
and Hsu WH: The prognostic value of the number of negative lymph
nodes in esophageal cancer patients after transthoracic resection.
Ann Thorac Surg. 96:995–1001. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Luketich JD, Kassis ES, Shriver SP, Nguyen
NT, Schauer PR, Weigel TL, Yousem SA and Siegfried JM: Detection of
micrometastases in histologically negative lymph nodes in
esophageal cancer. Ann Thorac Surg. 66:1715–1718. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Komukai S, Nishimaki T, Watanabe H, Ajioka
Y, Suzuki T and Hatakeyama K: Significance of immunohistochemically
demonstrated micrometastases to lymph nodes in esophageal cancer
with histologically negative nodes. Surgery. 127:40–46. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
de Meer SG, Dauwan M, de Keizer B, Valk
GD, Rinkes Borel IH and Vriens MR: Not the number but the location
of lymph nodes matters for recurrence rate and disease-free
survival in patients with differentiated thyroid cancer. World J
Surg. 36:1262–1267. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tanaka H, Ohira M, Kubo N, Muguruma K,
Yamashita Y, Sawada T and Hirakawa K: Association of location of
lymph node metastases with postoperative recurrence of esophageal
squamous cell carcinoma. Anticancer Res. 32:3421–3426.
2012.PubMed/NCBI
|
|
21
|
Yang HX, Xu Y, Fu JH, Wang JY, Lin P and
Rong TH: An evaluation of the number of lymph nodes examined and
survival for node-negative esophageal carcinoma: Data from China.
Ann Surg Oncol. 17:1901–1911. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lagergren J, Mattsson F, Zylstra J, Chang
F, Gossage J, Mason R, Lagergren P and Davies A: Extent of
lymphadenectomy and prognosis after esophageal cancer surgery. JAMA
Surg. 151:32–39. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
van der Schaaf M, Johar A, Wijnhoven B,
Lagergren P and Lagergren J: Extent of lymph node removal during
esophageal cancer surgery and survival. J Natl Cancer Inst.
107:pii: djv0432015.
|
|
24
|
Yodying H, Matsuda A, Miyashita M,
Matsumoto S, Sakurazawa N, Yamada M and Uchida E: Prognostic
significance of neutrophil-to-lymphocyte ratio and
platelet-to-lymphocyte ratio in oncologic outcomes of esophageal
cancer: A systematic review and meta-analysis. Ann Surg Oncol.
23:646–654. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sharaiha RZ, Halazun KJ, Mirza F, Port JL,
Lee PC, Neugut AI, Altorki NK and Abrams JA: Elevated preoperative
neutrophil: Lymphocyte ratio as a predictor of postoperative
disease recurrence in esophageal cancer. Ann Surg Oncol.
18:3362–3369. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang F, Sun P, Wang ZQ, de Wang S, Wang
Y, Zhang DS, Wang FH, Fu JH, Xu RH and Li YH: Low preoperative
albumin-globulin score predicts favorable survival in esophageal
squamous cell carcinoma. Oncotarget. 7:30550–30560. 2016.PubMed/NCBI
|
|
27
|
Fukushima H, Kobayashi M, Kawano K and
Morimoto S: Prognostic value of albumin/globulin ratio in patients
with upper tract urothelial carcinoma patients treated with radical
nephroureterectomy. Anticancer Res. 38:2329–2334. 2018.PubMed/NCBI
|
|
28
|
He J, Pan H, Liang W, Xiao D, Chen X, Guo
M and He J: Prognostic effect of Albumin-to-Globulin ratio in
patients with solid tumors: A systematic review and meta-analysis.
J Cancer. 8:4002–4010. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Suh B, Park S, Shin DW, Yun JM, Keam B,
Yang HK, Ahn E, Lee H, Park JH and Cho B: Low albumin-to-globulin
ratio associated with cancer incidence and mortality in generally
healthy adults. Ann Oncol. 25:2260–2266. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shibutani M, Maeda K, Nagahara H, Ohtani
H, Iseki Y, Ikeya T, Sugano K and Hirakawa K: The pretreatment
albumin to globulin ratio predicts chemotherapeutic outcomes in
patients with unresectable metastatic colorectal cancer. BMC
Cancer. 15:3472015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ji WH, Jiang YH, Ji YL, Li B and Mao WM:
Prechemotherapy neutrophil : lymphocyte ratio is superior to the
platelet : Lymphocyte ratio as a prognostic indicator for locally
advanced esophageal squamous cell cancer treated with neoadjuvant
chemotherapy. Dis Esophagus. 29:403–411. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yutong H, Xiaoli X, Shumei L, Shan S, Di L
and Baoen S: Increased neutrophil-lymphocyte ratio is a poor
prognostic factor in patients with esophageal cancer in a high
incidence area in China. Arch Med Res. 46:557–563. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xie X, Luo KJ, Hu Y, Wang JY and Chen J:
Prognostic value of preoperative platelet-lymphocyte and
neutrophil-lymphocyte ratio in patients undergoing surgery for
esophageal squamous cell cancer. Dis Esophagus. 29:79–85. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Matsuda S, Tsubosa Y, Niihara M, Sato H,
Takebayashi K, Kawamorita K, Mori K, Tsushima T, Yasui H, Takeuchi
H and Kitagawa Y: Distribution of lymph node metastasis and
clinical validity of gastric tube reconstruction in lower thoracic
esophageal squamous cell carcinoma with gastric invasion. Ann Surg
Oncol. 22:617–623. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wilke TJ, Bhirud AR and Lin C: A review of
the impact of preoperative chemoradiotherapy on outcome and
postoperative complications in esophageal cancer patients. Am J
Clin Oncol. 38:415–421. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yuasa Y, Seike J, Yoshida T, Takechi H,
Yamai H, Yamamoto Y, Furukita Y, Goto M, Minato T, Nishino T, et
al: Sentinel lymph node biopsy using intraoperative indocyanine
green fluorescence imaging navigated with preoperative CT
lymphography for superficial esophageal cancer. Ann Surg Oncol.
19:486–493. 2012. View Article : Google Scholar : PubMed/NCBI
|
